Delays in genomic testing can significantly impact lung cancer survival rates.

#GenomicTesting is critical for #LungCancer diagnosis and treatment, enabling access to innovative, personalised treatments.

Delays in testing can significantly impact survival rates.

Read our report on how we can speed up the #GenomicsTesting pathway▶️ ow.ly/Xu2B50V9wGC